Immune Checkpoint Inhibitor-Associated Cutaneous Adverse Events: Mechanisms of Occurrence.
Eshaq AM, Flanagan TW, Ba Abbad AA, Makarem ZAA, Bokir MS, Alasheq AK, Al Asheikh SA, Almashhor AM, Binyamani F, Al-Amoudi WA, Bawzir AS, Haikel Y, Megahed M, Hassan M.
Eshaq AM, et al. Among authors: flanagan tw.
Int J Mol Sci. 2024 Dec 26;26(1):88. doi: 10.3390/ijms26010088.
Int J Mol Sci. 2024.
PMID: 39795946
Free PMC article.
Review.